TapewireFind a company

person · Reporting owner

Nabel Gary J.

Disclosed activity across 3 companies

Tapewire entity
35576
SEC CIK
0001867450

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Candel Therapeutics, Inc.CADL · Entity 4969DirectorJune 23, 2026June 24, 2026
OPKO HEALTH, INC.OPK · Entity 4891Director · Chief Innovation OfficerMay 27, 2025May 29, 2025
SIGA TECHNOLOGIES INCSIGA · Entity 6205DirectorJune 09, 2026June 11, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Candel Therapeutics, Inc.

Report date June 23, 2026 · Filed June 24, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.08 · Expires 2036-06-23Direct32,000 Reported balance After 2026-06-23 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-06-23 · Grant · Acquired 32,000 · Balance 32,000

F1: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 23, 2027 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting.

Filing footnotes · ownership attribution and instrument terms

F1: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 23, 2027 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting.

OPKO HEALTH, INC.

Report date May 27, 2025 · Filed May 29, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.31 · Expires 2035-05-26Direct437,500 Reported balance After 2025-05-27 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2025-05-27 · Grant · Acquired 437,500 · Balance 437,500

F1: This option will vest in four equal annual installments beginning May 27, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: This option will vest in four equal annual installments beginning May 27, 2026.

SIGA TECHNOLOGIES INC

Report date June 09, 2026 · Filed June 11, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, par value $.0001 per shareSEC Table I · non-derivativeDirect73,754 Ending reported balance After 2026-06-09 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2026-06-09 · Exercise / conversion · Acquired 24,116 · Balance 80,989

F1: Restricted stock units ("RSUs") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the "Company") on a one-for-one basis.

Row 2 · 2026-06-09 · Disposition to issuer · Disposed 7,235 · Balance 73,754

F2: Reflects RSUs that were cash-settled, per the terms of the compensation program for Board Directors and as noted on the Form 4 filed on June 11, 2025. Partial cash-settlement of RSUs under the Board compensation program is designed to address tax obligations in connection with the vesting of RSUs.

Restricted Stock UnitesSEC Table II · derivative / convertible securityDirect0 Reported balance After 2026-06-09 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-06-09 · Exercise / conversion · Disposed 24,116 · Balance 0

F1: Restricted stock units ("RSUs") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the "Company") on a one-for-one basis.

F3: The RSUs were granted on June 10, 2025, and fully vested on the date of the Company's 2026 annual meeting of stockholders.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect34,169 Reported balance After 2026-06-09 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2026-06-09 · Grant · Acquired 34,169 · Balance 34,169

F4: RSUs represent contingent rights to receive common stock of the Company on a one-for-one basis, of which up to 10,251 RSUs are expected to settle in cash value thereof but may be settled in shares at the discretion of the Board of Directors.

F5: The RSUs fully vest on the date of the Company's 2027 annual meeting of stockholders.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted stock units ("RSUs") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the "Company") on a one-for-one basis.

F2: Reflects RSUs that were cash-settled, per the terms of the compensation program for Board Directors and as noted on the Form 4 filed on June 11, 2025. Partial cash-settlement of RSUs under the Board compensation program is designed to address tax obligations in connection with the vesting of RSUs.

F3: The RSUs were granted on June 10, 2025, and fully vested on the date of the Company's 2026 annual meeting of stockholders.

F4: RSUs represent contingent rights to receive common stock of the Company on a one-for-one basis, of which up to 10,251 RSUs are expected to settle in cash value thereof but may be settled in shares at the discretion of the Board of Directors.

F5: The RSUs fully vest on the date of the Company's 2027 annual meeting of stockholders.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 23, 2026 Filed Jun 24, 2026 20:28 UTC Candel Therapeutics, Inc. CADL · Entity 4969 GrantStock Option (Right to Buy) · Derivative 32,000 $0.00 Strike: $9.08 $0.00
Disclosure

SEC source: 0001867450-26-000002 · ownership.xml · derivative · entry 1

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,000

Underlying: Common Stock · 32,000 shares

Expires 2036-06-23

F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 23, 2027 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 01:14 UTC SIGA TECHNOLOGIES INC SIGA · Entity 6205 GrantRestricted Stock Units · Derivative 34,169 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-266390 · ownership.xml · derivative · entry 4

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,169

Underlying: Common Stock, par value $.0001 per share · 34,169 shares

Expires not disclosed

F4 · derivative.exercise_price: RSUs represent contingent rights to receive common stock of the Company on a one-for-one basis, of which up to 10,251 RSUs are expected to settle in cash value thereof but may be settled in shares at the discretion of the Board of Directors.

F5 · derivative.exercise_date: The RSUs fully vest on the date of the Company's 2027 annual meeting of stockholders.

F5 · derivative.expiration_date: The RSUs fully vest on the date of the Company's 2027 annual meeting of stockholders.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 01:14 UTC SIGA TECHNOLOGIES INC SIGA · Entity 6205 Exercise / conversionRestricted Stock Unites · Derivative 24,116 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-266390 · ownership.xml · derivative · entry 3

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $.0001 per share · 24,116 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSUs") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the "Company") on a one-for-one basis.

F3 · derivative.exercise_date: The RSUs were granted on June 10, 2025, and fully vested on the date of the Company's 2026 annual meeting of stockholders.

F3 · derivative.expiration_date: The RSUs were granted on June 10, 2025, and fully vested on the date of the Company's 2026 annual meeting of stockholders.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 01:14 UTC SIGA TECHNOLOGIES INC SIGA · Entity 6205 Disposition to issuerCommon Stock, par value $.0001 per share 7,235 $4.39 $31,761.65
Disclosure

SEC source: 0001193125-26-266390 · ownership.xml · nonDerivative · entry 2

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,754

F2 · kind: Reflects RSUs that were cash-settled, per the terms of the compensation program for Board Directors and as noted on the Form 4 filed on June 11, 2025. Partial cash-settlement of RSUs under the Board compensation program is designed to address tax obligations in connection with the vesting of RSUs.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 01:14 UTC SIGA TECHNOLOGIES INC SIGA · Entity 6205 Exercise / conversionCommon Stock, par value $.0001 per share 24,116 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-266390 · ownership.xml · nonDerivative · entry 1

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,989

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units ("RSUs") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the "Company") on a one-for-one basis.

Read SEC document
June 25, 2025 Filed Jun 26, 2025 12:30 UTC Candel Therapeutics, Inc. CADL · Entity 4969 GrantCommon Stock 5,353 $4.67 $24,998.51
Disclosure

SEC source: 0000950170-25-090192 · ownership.xml · nonDerivative · entry 1

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,353

F1 · kind: Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025.

Read SEC document
June 17, 2025 Filed Jun 18, 2025 12:33 UTC Candel Therapeutics, Inc. CADL · Entity 4969 GrantStock Option (Right to Buy) · Derivative 14,240 $0.00 Strike: $4.94 $0.00
Disclosure

SEC source: 0000950170-25-087699 · ownership.xml · derivative · entry 1

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,240

Underlying: Common Stock · 14,240 shares

Expires 2035-06-17

F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 17, 2026 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting.

Read SEC document
June 10, 2025 Filed Jun 11, 2025 20:29 UTC SIGA TECHNOLOGIES INC SIGA · Entity 6205 GrantRestricted Stock Units · Derivative 24,116 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-084856 · ownership.xml · derivative · entry 4

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,116

Underlying: Common Stock, par value $.0001 per share · 24,116 shares

Expires not disclosed

F4 · derivative.exercise_price: RSUs represent contingent rights to receive common stock of the Company on a one-for-one basis, of which up to 7,235 RSUs are expected to settle in cash value thereof but may be settled in shares at the discretion of the board of directors.

F5 · derivative.exercise_date: The RSUs fully vest on the date of the Company's 2026 annual meeting of stockholders.

F5 · derivative.expiration_date: The RSUs fully vest on the date of the Company's 2026 annual meeting of stockholders.

Read SEC document
June 10, 2025 Filed Jun 11, 2025 20:29 UTC SIGA TECHNOLOGIES INC SIGA · Entity 6205 Exercise / conversionRestricted Stock Units · Derivative 19,084 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-084856 · ownership.xml · derivative · entry 3

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $.0001 per share · 19,084 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSUs") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the "Company") on a one-for-one basis.

F3 · derivative.exercise_date: The RSUs were granted on June 11, 2024, and fully vested on the date of the Company's 2025 annual meeting of stockholders.

F3 · derivative.expiration_date: The RSUs were granted on June 11, 2024, and fully vested on the date of the Company's 2025 annual meeting of stockholders.

Read SEC document
June 10, 2025 Filed Jun 11, 2025 20:29 UTC SIGA TECHNOLOGIES INC SIGA · Entity 6205 Disposition to issuerCommon Stock, par value $.0001 per share 5,725 $6.22 $35,609.50
Disclosure

SEC source: 0000950170-25-084856 · ownership.xml · nonDerivative · entry 2

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,873

F2 · kind: Reflects RSUs that were cash-settled, per the terms of the compensation program for Board Directors and as noted on the Form 4 filed on June 13, 2024. Partial cash-settlement of RSUs under the Board compensation program is designed to address tax obligations in connection with the vesting of RSUs.

Read SEC document
June 10, 2025 Filed Jun 11, 2025 20:29 UTC SIGA TECHNOLOGIES INC SIGA · Entity 6205 Exercise / conversionCommon Stock, par value $.0001 per share 19,084 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-084856 · ownership.xml · nonDerivative · entry 1

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,598

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units ("RSUs") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the "Company") on a one-for-one basis.

Read SEC document
May 27, 2025 Filed May 29, 2025 21:02 UTC OPKO HEALTH, INC. OPK · Entity 4891 GrantStock Option (Right to Buy) · Derivative 437,500 $0.00 Strike: $1.31 $0.00
Disclosure

SEC source: 0000950170-25-079104 · ownership.xml · derivative · entry 1

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 437,500

Underlying: Common Stock · 437,500 shares

Expires 2035-05-26

F1 · derivative.exercise_date: This option will vest in four equal annual installments beginning May 27, 2026.

Read SEC document
July 24, 2024 Filed Jul 26, 2024 23:05 UTC OPKO HEALTH, INC. OPK · Entity 4891 GrantCommon Stock 437,500 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-087030 · ownership.xml · nonDerivative · entry 1

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 700,579

F1 · security: Each restricted stock unit represents a contingent right to receive one share of OPKO common stock upon the vesting of the award. The restricted stock units vest 50% on the second anniversary of the grant date, then 25% on each of the following two years.

Read SEC document
June 26, 2024 Filed Jun 27, 2024 12:39 UTC Candel Therapeutics, Inc. CADL · Entity 4969 GrantStock Option (Right to Buy) · Derivative 14,240 $0.00 Strike: $5.71 $0.00
Disclosure

SEC source: 0000950170-24-078173 · ownership.xml · derivative · entry 1

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,240

Underlying: Common Stock · 14,240 shares

Expires 2034-06-26

F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 26, 2025 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting.

Read SEC document
June 11, 2024 Filed Jun 13, 2024 20:18 UTC SIGA TECHNOLOGIES INC SIGA · Entity 6205 GrantRestricted Stock Units · Derivative 19,084 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-073033 · ownership.xml · derivative · entry 4

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,084

Underlying: Common Stock, par value $.0001 per share · 19,084 shares

Expires not disclosed

F4 · derivative.exercise_price: RSUs represent contingent rights to receive common stock of the Company on a one-for-one basis, of which up to 5,725 RSUs are expected to settle in cash value thereof but may be settled in shares at the discretion of the board of directors.

F5 · derivative.exercise_date: The RSUs fully vest on the date of the Company's 2025 annual meeting of stockholders.

F5 · derivative.expiration_date: The RSUs fully vest on the date of the Company's 2025 annual meeting of stockholders.

Read SEC document
June 11, 2024 Filed Jun 13, 2024 20:18 UTC SIGA TECHNOLOGIES INC SIGA · Entity 6205 Exercise / conversionRestricted Stock Units · Derivative 24,712 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-073033 · ownership.xml · derivative · entry 3

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $.0001 per share · 24,712 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSUs") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the "Company") on a one-for-one basis.

F3 · derivative.exercise_date: The RSUs were granted on June 13, 2023, and fully vested on the date of the Company's 2024 annual meeting of stockholders.

F3 · derivative.expiration_date: The RSUs were granted on June 13, 2023, and fully vested on the date of the Company's 2024 annual meeting of stockholders.

Read SEC document
June 11, 2024 Filed Jun 13, 2024 20:18 UTC SIGA TECHNOLOGIES INC SIGA · Entity 6205 Disposition to issuerCommon Stock, par value $.0001 per share 7,414 $7.86 $58,274.04
Disclosure

SEC source: 0000950170-24-073033 · ownership.xml · nonDerivative · entry 2

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,514

F2 · kind: Reflects RSUs that were cash-settled, per the terms of the compensation program for Board Directors and as noted on the Form 4 filed on June 15, 2023. Partial cash-settlement of RSUs under the Board compensation program is designed to address tax obligations in connection with the vesting of RSUs.

Read SEC document
June 11, 2024 Filed Jun 13, 2024 20:18 UTC SIGA TECHNOLOGIES INC SIGA · Entity 6205 Exercise / conversionCommon Stock, par value $.0001 per share 24,712 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-073033 · ownership.xml · nonDerivative · entry 1

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,928

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units ("RSUs") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the "Company") on a one-for-one basis.

Read SEC document
January 08, 2024 Filed Jan 10, 2024 22:56 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 106,989 $0.93 $99,424.88
Disclosure

SEC source: 0000950170-24-003699 · ownership.xml · nonDerivative · entry 3

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 107,489

F2 · balance_after: Shares held by the Elizabeth G. Nabel ROTH Contributory IRA. Excludes 113,200 shares purchased in 2022. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F2 · ownership.nature: Shares held by the Elizabeth G. Nabel ROTH Contributory IRA. Excludes 113,200 shares purchased in 2022. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
January 08, 2024 Filed Jan 10, 2024 22:56 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 500 $0.92 $458.90
Disclosure

SEC source: 0000950170-24-003699 · ownership.xml · nonDerivative · entry 2

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 500

F2 · ownership.nature: Shares held by the Elizabeth G. Nabel ROTH Contributory IRA. Excludes 113,200 shares purchased in 2022. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
January 08, 2024 Filed Jan 10, 2024 22:56 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 108,695 $0.93 $100,542.88
Disclosure

SEC source: 0000950170-24-003699 · ownership.xml · nonDerivative · entry 1

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 351,442

F1 · ownership.nature: Shares held by the Nabel Family Investments LLC, of which the Reporting Person is the manager with sole investment power and has an approximately 48% interest through the parent trust, the 2009 Nabel Family Children's Trust of which the Reporting Person has sole control, and sole investment power. The Reporting Per disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be dee admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
June 28, 2023 Filed Jun 29, 2023 13:00 UTC Candel Therapeutics, Inc. CADL · Entity 4969 GrantStock Option (Right to Buy) · Derivative 14,240 $0.00 Strike: $1.22 $0.00
Disclosure

SEC source: 0001209191-23-040130 · doc4.xml · derivative · entry 1

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,240

Underlying: Common Stock · 14,240 shares

Expires 2033-06-28

F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 28, 2024 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting.

Read SEC document
June 13, 2023 Filed Jun 15, 2023 21:15 UTC SIGA TECHNOLOGIES INC SIGA · Entity 6205 GrantRestricted Stock Units · Derivative 24,712 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-037429 · doc4.xml · derivative · entry 4

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,712

Underlying: Common Stock, par value $.0001 per share · 24,712 shares

Expires not disclosed

F4 · derivative.exercise_price: RSUs represent contingent rights to receive common stock of the Company on a one-for-one basis, of which up to 7,414 RSUs are expected to settle in cash value thereof but may be settled in shares at the discretion of the board of directors.

F5 · derivative.exercise_date: The RSUs fully vest on the date of the Company's 2024 annual meeting of stockholders.

F5 · derivative.expiration_date: The RSUs fully vest on the date of the Company's 2024 annual meeting of stockholders.

Read SEC document
June 13, 2023 Filed Jun 15, 2023 21:15 UTC SIGA TECHNOLOGIES INC SIGA · Entity 6205 Exercise / conversionRestricted Stock Units · Derivative 14,620 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-037429 · doc4.xml · derivative · entry 3

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $.0001 per share · 14,620 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSUs") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the "Company") on a one-for-one basis.

F3 · derivative.exercise_date: The RSUs were granted on June 14, 2022, and fully vested on the date of the Company's 2023 annual meeting of stockholders.

F3 · derivative.expiration_date: The RSUs were granted on June 14, 2022, and fully vested on the date of the Company's 2023 annual meeting of stockholders.

Read SEC document
June 13, 2023 Filed Jun 15, 2023 21:15 UTC SIGA TECHNOLOGIES INC SIGA · Entity 6205 Disposition to issuerCommon Stock, par value $.0001 per share 4,386 $6.07 $26,623.02
Disclosure

SEC source: 0001209191-23-037429 · doc4.xml · nonDerivative · entry 2

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,216

F2 · kind: Reflects RSUs that were cash-settled, per the terms of the compensation program for Board Directors and as noted on the Form 4 filed on June 16, 2022. Partial cash-settlement of RSUs under the Board compensation program is designed to address tax obligations in connection with the vesting of RSUs.

Read SEC document
June 13, 2023 Filed Jun 15, 2023 21:15 UTC SIGA TECHNOLOGIES INC SIGA · Entity 6205 Exercise / conversionCommon Stock, par value $.0001 per share 14,620 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-037429 · doc4.xml · nonDerivative · entry 1

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,602

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units ("RSUs") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the "Company") on a one-for-one basis.

Read SEC document
May 18, 2023 Filed May 19, 2023 20:36 UTC OPKO HEALTH, INC. OPK · Entity 4891 GrantStock Option (Right to Buy) · Derivative 700,000 $0.00 Strike: $1.58 $0.00
Disclosure

SEC source: 0001209191-23-031030 · doc4.xml · derivative · entry 1

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 700,000

Underlying: Common Stock · 700,000 shares

Expires 2033-05-17

F1 · derivative.exercise_date: This option will vest in four equal annual installments beginning May 18, 2024.

Read SEC document
May 05, 2023 Filed May 8, 2023 11:03 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 54,054 $1.85 $99,999.90
Disclosure

SEC source: 0001209191-23-027852 · doc4.xml · nonDerivative · entry 14

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 242,747

F3 · ownership.nature: Shares held by the Nabel Family Investments LLC, of which the Reporting Person is the manager with sole investment power and has an approximately 48% interest through the parent trust, the 2009 Nabel Family Children's Trust of which the Reporting Person has sole control, and sole investment power. The Reporting Per disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
May 05, 2023 Filed May 8, 2023 11:03 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 20,009 $1.85 $36,960.62
Disclosure

SEC source: 0001209191-23-027852 · doc4.xml · nonDerivative · entry 13

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 188,693

F3 · ownership.nature: Shares held by the Nabel Family Investments LLC, of which the Reporting Person is the manager with sole investment power and has an approximately 48% interest through the parent trust, the 2009 Nabel Family Children's Trust of which the Reporting Person has sole control, and sole investment power. The Reporting Per disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
May 05, 2023 Filed May 8, 2023 11:03 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 54,346 $1.84 $99,991.21
Disclosure

SEC source: 0001209191-23-027852 · doc4.xml · nonDerivative · entry 12

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 168,684

F3 · ownership.nature: Shares held by the Nabel Family Investments LLC, of which the Reporting Person is the manager with sole investment power and has an approximately 48% interest through the parent trust, the 2009 Nabel Family Children's Trust of which the Reporting Person has sole control, and sole investment power. The Reporting Per disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
May 05, 2023 Filed May 8, 2023 11:03 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 34,338 $1.84 $63,113.24
Disclosure

SEC source: 0001209191-23-027852 · doc4.xml · nonDerivative · entry 11

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 114,338

F3 · ownership.nature: Shares held by the Nabel Family Investments LLC, of which the Reporting Person is the manager with sole investment power and has an approximately 48% interest through the parent trust, the 2009 Nabel Family Children's Trust of which the Reporting Person has sole control, and sole investment power. The Reporting Per disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
May 05, 2023 Filed May 8, 2023 11:03 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 54,945 $1.82 $99,999.90
Disclosure

SEC source: 0001209191-23-027852 · doc4.xml · nonDerivative · entry 10

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 19,912,459

F2 · ownership.nature: Shares held by the EGN 2021 TRUST for the benefit of the Reporting Person and his descendants, and for which an independent trustee has been appointed. The Reporting Person and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
May 05, 2023 Filed May 8, 2023 11:03 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 26,407 $1.85 $48,852.95
Disclosure

SEC source: 0001209191-23-027852 · doc4.xml · nonDerivative · entry 9

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 19,912,459

F1 · ownership.nature: Shares held by the GJN 2021 TRUST for the benefit of the Reporting Person's spouse and descendants, and for which the Reporting Person's spouse serves as co-trustee together with an independent trustee. The Reporting Person's spouse and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
May 05, 2023 Filed May 8, 2023 11:03 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 28,538 $1.82 $51,939.16
Disclosure

SEC source: 0001209191-23-027852 · doc4.xml · nonDerivative · entry 8

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 19,886,052

F1 · ownership.nature: Shares held by the GJN 2021 TRUST for the benefit of the Reporting Person's spouse and descendants, and for which the Reporting Person's spouse serves as co-trustee together with an independent trustee. The Reporting Person's spouse and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
May 05, 2023 Filed May 8, 2023 11:03 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 10,928 $1.83 $19,998.24
Disclosure

SEC source: 0001209191-23-027852 · doc4.xml · nonDerivative · entry 7

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 263,079

Read SEC document
May 05, 2023 Filed May 8, 2023 11:03 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 19,475 $1.83 $35,619.78
Disclosure

SEC source: 0001209191-23-027852 · doc4.xml · nonDerivative · entry 6

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 252,151

Read SEC document
May 05, 2023 Filed May 8, 2023 11:03 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 79,334 $1.82 $144,387.88
Disclosure

SEC source: 0001209191-23-027852 · doc4.xml · nonDerivative · entry 5

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 232,676

Read SEC document
May 05, 2023 Filed May 8, 2023 11:03 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 27,624 $1.81 $49,999.44
Disclosure

SEC source: 0001209191-23-027852 · doc4.xml · nonDerivative · entry 4

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,342

Read SEC document
May 05, 2023 Filed May 8, 2023 11:03 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 27,777 $1.80 $49,998.60
Disclosure

SEC source: 0001209191-23-027852 · doc4.xml · nonDerivative · entry 3

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,718

Read SEC document
May 05, 2023 Filed May 8, 2023 11:03 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 3,185 $1.79 $5,710.71
Disclosure

SEC source: 0001209191-23-027852 · doc4.xml · nonDerivative · entry 2

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,941

Read SEC document
May 05, 2023 Filed May 8, 2023 11:03 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 19,285 $1.78 $34,327.30
Disclosure

SEC source: 0001209191-23-027852 · doc4.xml · nonDerivative · entry 1

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,756

Read SEC document
August 08, 2022 Filed Aug 10, 2022 12:05 UTC Candel Therapeutics, Inc. CADL · Entity 4969 GrantStock Option (Right to Buy) · Derivative 28,480 $0.00 Strike: $3.38 $0.00
Disclosure

SEC source: 0000899243-22-028202 · doc4.xml · derivative · entry 1

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,480

Underlying: Common Stock · 28,480 shares

Expires 2032-08-08

F1 · derivative.exercise_date: 33% of the shares underlying this option shall vest and become exercisable on August 8, 2023, with the remainder vesting in two (2) equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
June 22, 2022 Filed Jun 24, 2022 23:52 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 80,000 $2.47 $197,600.00
Disclosure

SEC source: 0001209191-22-039341 · doc4.xml · nonDerivative · entry 8

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Nabel Family Investments LLC

Disclosed balance after: 80,000

F3 · ownership.nature: Shares held by the Nabel Family Investments LLC, of which the Reporting Person is the manager with sole investment power and has an approximately 48% interest through the parent trust, the 2009 Nabel Family Children's Trust of which the Reporting Person has sole control, and sole investment power. The Reporting Per disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be dee admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
June 22, 2022 Filed Jun 24, 2022 23:52 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 33,777 $2.50 $84,442.50
Disclosure

SEC source: 0001209191-22-039341 · doc4.xml · nonDerivative · entry 7

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by the EGN 2021 TRUST

Disclosed balance after: 19,857,514

F2 · ownership.nature: Shares held by the EGN 2021 TRUST for the benefit of the Reporting Person and his descendants, and for which an independent trustee has been appointed. The Reporting Person and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
June 22, 2022 Filed Jun 24, 2022 23:52 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 15,200 $2.50 $37,962.00
Disclosure

SEC source: 0001209191-22-039341 · doc4.xml · nonDerivative · entry 6

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by the EGN 2021 TRUST

Disclosed balance after: 19,823,737

F2 · ownership.nature: Shares held by the EGN 2021 TRUST for the benefit of the Reporting Person and his descendants, and for which an independent trustee has been appointed. The Reporting Person and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
June 22, 2022 Filed Jun 24, 2022 23:52 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 31,023 $2.50 $77,402.39
Disclosure

SEC source: 0001209191-22-039341 · doc4.xml · nonDerivative · entry 5

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by the EGN 2021 TRUST

Disclosed balance after: 19,808,537

F2 · ownership.nature: Shares held by the EGN 2021 TRUST for the benefit of the Reporting Person and his descendants, and for which an independent trustee has been appointed. The Reporting Person and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
June 22, 2022 Filed Jun 24, 2022 23:52 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 13,229 $2.50 $33,072.50
Disclosure

SEC source: 0001209191-22-039341 · doc4.xml · nonDerivative · entry 4

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by the GJN 2021 TRUST

Disclosed balance after: 19,857,514

F1 · ownership.nature: Shares held by the GJN 2021 TRUST for the benefit of the Reporting Person's spouse and descendants, and for which the Reporting Person's spouse serves as co-trustee together with an independent trustee. The Reporting Person's spouse and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
June 22, 2022 Filed Jun 24, 2022 23:52 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 65,280 $2.50 $163,193.47
Disclosure

SEC source: 0001209191-22-039341 · doc4.xml · nonDerivative · entry 3

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by the GJN 2021 TRUST

Disclosed balance after: 19,844,285

F1 · ownership.nature: Shares held by the GJN 2021 TRUST for the benefit of the Reporting Person's spouse and descendants, and for which the Reporting Person's spouse serves as co-trustee together with an independent trustee. The Reporting Person's spouse and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
June 22, 2022 Filed Jun 24, 2022 23:52 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 1,491 $2.50 $3,720.05
Disclosure

SEC source: 0001209191-22-039341 · doc4.xml · nonDerivative · entry 2

Nabel Gary J. · CIK 0001867450 · Director · Chief Innovation Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by the GJN 2021 TRUST

Disclosed balance after: 19,779,005

F1 · ownership.nature: Shares held by the GJN 2021 TRUST for the benefit of the Reporting Person's spouse and descendants, and for which the Reporting Person's spouse serves as co-trustee together with an independent trustee. The Reporting Person's spouse and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
June 14, 2022 Filed Jun 16, 2022 21:47 UTC SIGA TECHNOLOGIES INC SIGA · Entity 6205 GrantRestricted Stock Units · Derivative 14,620 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-037562 · doc4.xml · derivative · entry 4

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,620

Underlying: Common Stock, par value $.0001 per share · 14,620 shares

Expires not disclosed

F4 · derivative.exercise_price: RSUs represent contingent rights to receive common stock of the Company on a one-for-one basis, of which up to 4,386 RSUs are expected to settle in cash value thereof but may be settled in shares at the discretion of the board of directors.

F5 · derivative.exercise_date: The RSUs fully vest on the date of the Company's 2023 annual meeting of stockholders.

F5 · derivative.expiration_date: The RSUs fully vest on the date of the Company's 2023 annual meeting of stockholders.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.